Neutrophils in COVID-19
Open accessThe DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Abstract
Strong evidence has been accumulated since the beginning of the COVID-19 pandemic that neutrophils play an important role in the pathophysiology, particularly in those with severe disease courses. While originally considered to be a rather homogeneous cell type, recent attention to neutrophils has uncovered their fascinating transcriptional and functional diversity as well as their developmental trajectories. These new findings are important to better understand the many facets of neutrophil involvement not only in COVID-19 but also many other acute or chronic inflammatory diseases, both communicable and non-communicable. Here, we highlight the observed immune deviation of neutrophils in COVID-19 and summarize several promising therapeutic attempts to precisely target neutrophils and their reactivity in patients with COVID-19.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Dexamethasone in Hospitalized Patients with Covid-19
The RECOVERY Collaborative Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2021436 · Cited by 11,477
Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report
Horby, P., Lim, W. S., Emberson, J., Mafham, M., Bell, J., Linsell, L., Staplin, N., Brightling, C., Ustianowski, A., Elmahi, E., et al. (2020) · doi:10.1101/2020.06.22.20137273 · Cited by 11,475 · cited 1×
“Corticosteroids are a currently recommended treatment for severe COVID-19 (104) shown to reduce neutrophils’ respiratory burst and recruitment to the inflamed tissue at system level (105) and inhaled glucocorticoids have been shown to reduce NET formation in asthma patients (106).”
BackgroundNeutrophil Extracellular Traps Kill Bacteria
Brinkmann, V., Reichard, U., Goosmann, C., Fauler, B., Uhlemann, Y., Weiss, D. S., Weinrauch, Y., & Zychlinsky, A. (2004) · Science · doi:10.1126/science.1092385 · Cited by 10,268 · cited 1×
“Additionally, they can form neutrophil extracellular traps (NETs), in which parts of the nucleus together with granules are actively released (25).”
BackgroundDysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa248 · Cited by 4,775
Clinical and immunological features of severe and moderate coronavirus disease 2019
Chen, G., Wu, D., Guo, W., Cao, Y., Huang, D., Wang, H., Wang, T., Zhang, X., Chen, H., Yu, H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137244 · Cited by 4,750 · cited 1×
“As lower levels of IFNg production by lymphocytes have been reported early on (66), these immunosuppressive neutrophils may contribute to this phenotype.”
BackgroundRecommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Bronte, V., Brandau, S., Chen, S.-H., Colombo, M. P., Frey, A. B., Greten, T. F., Mandruzzato, S., Murray, P. J., Ochoa, A., Ostrand-Rosenberg, S., et al. (2016) · Nature Communications · doi:10.1038/ncomms12150 · Cited by 2,751 · cited 1×
“So-called granulocytic myeloid-derived suppressor cells (MDSC), originally identified in cancer (42, 43), have now additionally been described in multiple viral chronic infections, such as HCV (44) and HIV (45–47), to inhibit lymphocyte proliferation via depletion of arginine by Arginase-1 (48) or through the expressi…”
BackgroundSingle-cell landscape of bronchoalveolar immune cells in patients with COVID-19
Liao, M., Liu, Y., Yuan, J., Wen, Y., Xu, G., Zhao, J., Cheng, L., Li, J., Wang, X., Wang, F., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0901-9 · Cited by 2,614 · cited 2×
“Upon SARS-CoV-2 infection, elevated numbers of neutrophils have been observed in the nasopharyngeal epithelium (55) and later in the more distal parts of the lung (56).”
BackgroundLongitudinal analyses reveal immunological misfiring in severe COVID-19
Lucas, C., Wong, P., Klein, J., Castro, T. B. R., Silva, J., Sundaram, M., Ellingson, M. K., Mao, T., Oh, J. E., Israelow, B., et al. (2020) · Nature · doi:10.1038/s41586-020-2588-y · Cited by 2,074 · cited 1×
“The risk of immunothrombosis is further increased by vasoconstriction caused by the cytokine release syndrome observed in severe COVID-19 (76) or by hypoxic pulmonary vasoconstriction which is possibly dysregulated in severe COVID-19 (77, 78).”
BackgroundComplex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure
Giamarellos-Bourboulis, E. J., Netea, M. G., Rovina, N., Akinosoglou, K., Antoniadou, A., Antonakos, N., Damoraki, G., Gkavogianni, T., Adami, M.-E., Katsaounou, P., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.04.009 · Cited by 2,045
Klok, F. A., Kruip, M. J. H. A., van der Meer, N. J. M., Arbous, M. S., Gommers, D., Kant, K. M., Kaptein, F. H. J., van Paassen, J., Stals, M. A. M., Huisman, M. V., et al. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.04.041 · Cited by 1,601
Neutrophil extracellular traps in COVID-19
Zuo, Y., Yalavarthi, S., Shi, H., Gockman, K., Zuo, M., Madison, J. A., Blair, C. N., Weber, A., Barnes, B. J., Egeblad, M., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.138999 · Cited by 1,582
Targeting potential drivers of COVID-19: Neutrophil extracellular traps
Barnes, B. J., Adrover, J. M., Baxter-Stoltzfus, A., Borczuk, A., Cools-Lartigue, J., Crawford, J. M., Daßler-Plenker, J., Guerci, P., Huynh, C., Knight, J. S., et al. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20200652 · Cited by 1,486
Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment
Schulte-Schrepping, J., Reusch, N., Paclik, D., Baßler, K., Schlickeiser, S., Zhang, B., Krämer, B., Krammer, T., Brumhard, S., Bonaguro, L., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.001 · Cited by 1,461
Self-citationMiddleton, E. A., He, X.-Y., Denorme, F., Campbell, R. A., Ng, D., Salvatore, S. P., Mostyka, M., Baxter-Stoltzfus, A., Borczuk, A. C., Loda, M., et al. (2020) · Blood · doi:10.1182/blood.2020007008 · Cited by 1,460
Contribution of Neutrophils to Acute Lung Injury
Grommes, J., & Soehnlein, O. (2011) · Molecular Medicine · doi:10.2119/molmed.2010.00138 · Cited by 1,313 · cited 1×
“In acute respiratory distress syndrome for instance, excessive neutrophil activation can lead to an increased permeability of blood vessels due to released defensins and neutrophil elastase (NE) (38, 39).”
BackgroundNeutrophil diversity and plasticity in tumour progression and therapy
Jaillon, S., Ponzetta, A., Di Mitri, D., Santoni, A., Bonecchi, R., & Mantovani, A. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0281-y · Cited by 1,285 · cited 1×
“Thus, knowledge on this most abundant but also technically challenging immune cell fraction in blood is lagging behind (5).”
BackgroundThe Neutrophil’s Role During Health and Disease
Liew, P. X., & Kubes, P. (2019) · Physiological Reviews · doi:10.1152/physrev.00012.2018 · Cited by 1,175 · cited 2×
“Yet, if not properly regulated, the powerful effector functions of these cells can lead to tissue damage (8).”
BackgroundChua, R. L., Lukassen, S., Trump, S., Hennig, B. P., Wendisch, D., Pott, F., Debnath, O., Thürmann, L., Kurth, F., Völker, M. T., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0602-4 · Cited by 1,035 · cited 2×
“Upon SARS-CoV-2 infection, elevated numbers of neutrophils have been observed in the nasopharyngeal epithelium (55) and later in the more distal parts of the lung (56).”
BackgroundCOVID-19: the vasculature unleashed
Teuwen, L.-A., Geldhof, V., Pasut, A., & Carmeliet, P. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0343-0 · Cited by 1,008
Platelet gene expression and function in patients with COVID-19
Manne, B. K., Denorme, F., Middleton, E. A., Portier, I., Rowley, J. W., Stubben, C., Petrey, A. C., Tolley, N. D., Guo, L., Cody, M., et al. (2020) · Blood · doi:10.1182/blood.2020007214 · Cited by 946 · cited 1×
“Another pathophysiological mechanism linked to neutrophils in severe COVID-19 is the increase in platelet-neutrophil aggregates that contribute to increased levels of NET formation (67, 74, 75).”
BackgroundSARS-CoV-2–triggered neutrophil extracellular traps mediate COVID-19 pathology
Veras, F. P., Pontelli, M. C., Silva, C. M., Toller-Kawahisa, J. E., de Lima, M., Nascimento, D. C., Schneider, A. H., Caetité, D., Tavares, L. A., Paiva, I. M., et al. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20201129 · Cited by 933 · cited 3×
“NETs were also suggested to kill lung epithelial cells (70).”
BackgroundHypoxia-induced neutrophil survival is mediated by HIF-1α–dependent NF-κB activity
Walmsley, S. R., Print, C., Farahi, N., Peyssonnaux, C., Johnson, R. S., Cramer, T., Sobolewski, A., Condliffe, A. M., Cowburn, A. S., Johnson, N., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20040624 · Cited by 891
Narasaraju, T., Yang, E., Samy, R. P., Ng, H. H., Poh, W. P., Liew, A.-A., Phoon, M. C., van Rooijen, N., & Chow, V. T. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.03.013 · Cited by 890 · cited 1×
“In addition, NET formation may not only activate alveolar macrophages for clearance (40), but also largely contributes to the activation of endothelial cells exacerbating the inflammatory circuit (37) or can actively damage endothelial tissue (41).”
BackgroundSingle-cell transcriptome profiling reveals neutrophil heterogeneity in homeostasis and infection
Xie, X., Shi, Q., Wu, P., Zhang, X., Kambara, H., Su, J., Yu, H., Park, S.-Y., Guo, R., Ren, Q., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-0736-z · Cited by 859 · cited 6×
“This leads to a decrease in mRNA content over their course of life (6) and thus a potential discrepancy between protein and gene expression (15).”
BackgroundInfluentialManz, M. G., & Boettcher, S. (2014) · Nature Reviews Immunology · doi:10.1038/nri3660 · Cited by 855 · cited 1×
“This mechanism results in the presence of both immature neutrophils and mature populations in the peripheral blood, that can act either immunosuppressive or pro-inflammatory (11, 51).”
BackgroundElevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19
Silvin, A., Chapuis, N., Dunsmore, G., Goubet, A.-G., Dubuisson, A., Derosa, L., Almire, C., Hénon, C., Kosmider, O., Droin, N., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.002 · Cited by 834 · cited 3×
“Spectral flow cytometry furthermore confirmed the substantial increase in immature/ pre-Neu, here defined by CD10CD101 expression, in patients with severe COVID-19 (59).”
Rodriguez, P. C., Ernstoff, M. S., Hernandez, C., Atkins, M., Zabaleta, J., Sierra, R., & Ochoa, A. C. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1921 · Cited by 773 · cited 1×
“So-called granulocytic myeloid-derived suppressor cells (MDSC), originally identified in cancer (42, 43), have now additionally been described in multiple viral chronic infections, such as HCV (44) and HIV (45–47), to inhibit lymphocyte proliferation via depletion of arginine by Arginase-1 (48) or through the expressi…”
BackgroundMartin, C., Burdon, P. C. E., Bridger, G., Gutierrez-Ramos, J.-C., Williams, T. J., & Rankin, S. M. (2003) · Immunity · doi:10.1016/s1074-7613(03)00263-2 · Cited by 770 · cited 1×
“A switch in chemokine receptor expression from CXCR4 to CXCR2, finally, leads to the egress of mature neutrophils from the BM into the circulation (16, 17).”
BackgroundRhythmic Modulation of the Hematopoietic Niche through Neutrophil Clearance
Casanova-Acebes, M., Pitaval, C., Weiss, L. A., Nombela-Arrieta, C., Chèvre, R., A-González, N., Kunisaki, Y., Zhang, D., van Rooijen, N., Silberstein, L. E., et al. (2013) · Cell · doi:10.1016/j.cell.2013.04.040 · Cited by 748 · cited 1×
“the downregulation of CXCR4 is responsible for the egress of neutrophils from the BM, the re-expression of CXCR4 on aged neutrophils will eventually lead to the migration back into the BM, spleen, or liver where aged neutrophils are phagocytosed by macrophages (18, 19).”
BackgroundCircuits between infected macrophages and T cells in SARS-CoV-2 pneumonia
Grant, R. A., Morales-Nebreda, L., Markov, N. S., Swaminathan, S., Querrey, M., Guzman, E. R., Abbott, D. A., Donnelly, H. K., Donayre, A., Goldberg, I. A., et al. (2021) · Nature · doi:10.1038/s41586-020-03148-w · Cited by 727 · cited 1×
“In contrast, a study based on flow cytometry data did not find increased neutrophil counts in severe COVID-19 patients in bronchoalveolar lavage as compared to other ICU patients (either non-pneumonia or pneumonia) (88).”
ResultNg, L. G., Ostuni, R., & Hidalgo, A. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0141-8 · Cited by 725
Interdependence of hypoxic and innate immune responses
Nizet, V., & Johnson, R. S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2607 · Cited by 708 · cited 1×
“org 3 upregulated in hypoxic conditions of inflamed tissue (34).”
BackgroundEvrard, M., Kwok, I. W. H., Chong, S. Z., Teng, K. W. W., Becht, E., Chen, J., Sieow, J. L., Penny, H. L., Ching, G. C., Devi, S., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.02.002 · Cited by 705 · cited 1×
“Phagocytosis capacity as well as ROS production increase with maturation stage (6, 12).”
BackgroundProthrombotic autoantibodies in serum from patients hospitalized with COVID-19
Zuo, Y., Estes, S. K., Ali, R. A., Gandhi, A. A., Yalavarthi, S., Shi, H., Sule, G., Gockman, K., Madison, J. A., Zuo, M., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.abd3876 · Cited by 660 · cited 1×
“At least 50% of the patients in this study were positive for anti-phospholipid autoantibodies that may explain this effect (72).”
BackgroundNeutrophils as emerging therapeutic targets
Németh, T., Sperandio, M., & Mócsai, A. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0054-z · Cited by 653
Neutrophils scan for activated platelets to initiate inflammation
Sreeramkumar, V., Adrover, J. M., Ballesteros, I., Cuartero, M. I., Rossaint, J., Bilbao, I., Nácher, M., Pitaval, C., Radovanovic, I., Fukui, Y., et al. (2014) · Science · doi:10.1126/science.1256478 · Cited by 650 · cited 1×
“Additionally, a growing body of evidence shows a link between neutrophils and activated platelets that guide their migration into inflamed tissue and induce NET formation (30, 31).”
BackgroundAnakinra for severe forms of COVID-19: a cohort study
Huet, T., Beaussier, H., Voisin, O., Jouveshomme, S., Dauriat, G., Lazareth, I., Sacco, E., Naccache, J.-M., Bézie, Y., Laplanche, S., et al. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30164-8 · Cited by 643
Host DNases prevent vascular occlusion by neutrophil extracellular traps
Jiménez-Alcázar, M., Rangaswamy, C., Panda, R., Bitterling, J., Simsek, Y. J., Long, A. T., Bilyy, R., Krenn, V., Renné, C., Renné, T., et al. (2017) · Science · doi:10.1126/science.aam8897 · Cited by 594 · cited 1×
“Together, neutrophils and activated platelets can elicit a process termed immunothrombosis in blood vessels where they contribute to the formation of a fibrin mesh that can trap pathogens (32), but more importantly intravascular NET formation by itself can lead to the fibrin-independent occlusion of microvessels causi…”
BackgroundStroke in COVID-19: A systematic review and meta-analysis
Nannoni, S., de Groot, R., Bell, S., & Markus, H. S. (2021) · International Journal of Stroke · doi:10.1177/1747493020972922 · Cited by 584
Association of COVID-19 inflammation with activation of the C5a–C5aR1 axis
Carvelli, J., Demaria, O., Vély, F., Batista, L., Chouaki Benmansour, N., Fares, J., Carpentier, S., Thibult, M.-L., Morel, A., Remark, R., et al. (2020) · Nature · doi:10.1038/s41586-020-2600-6 · Cited by 526 · cited 1×
“The C5a molecule was found to increase proportionally with COVID-19 severity (101) and is known to induce neutrophil recruitment as well as activation by binding the C5aR1 receptor (28).”
BackgroundNeutrophil Diversity in Health and Disease
Silvestre-Roig, C., Fridlender, Z. G., Glogauer, M., & Scapini, P. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.04.012 · Cited by 522 · cited 4×
“The distinction between immunosuppressive and proinflammatory LDNs is still solely based on functional assays since no cellular markers were identified to distinguish the two subsets, underlining the need for further studies to fully understand their origin and function (23).”
BackgroundInfluentialVisualizing the function and fate of neutrophils in sterile injury and repair
Wang, J., Hossain, M., Thanabalasuriar, A., Gunzer, M., Meininger, C., & Kubes, P. (2017) · Science · doi:10.1126/science.aam9690 · Cited by 508 · cited 1×
“Previously extravasated neutrophils may also re-enter circulation, migrate to the pulmonary microcirculation where they upregulate CXCR4 to subsequently enter the BM for clearance (20).”
BackgroundCo-option of Neutrophil Fates by Tissue Environments
Ballesteros, I., Rubio-Ponce, A., Genua, M., Lusito, E., Kwok, I., Fernández-Calvo, G., Khoyratty, T. E., van Grinsven, E., González-Hernández, S., Nicolás-Ávila, J. Á., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.003 · Cited by 504 · cited 2×
“Once in circulation, neutrophils either patrol the vasculature or migrate into different organs (7).”
BackgroundVascular occlusion by neutrophil extracellular traps in COVID-19
Leppkes, M., Knopf, J., Naschberger, E., Lindemann, A., Singh, J., Herrmann, I., Stürzl, M., Staats, L., Mahajan, A., Schauer, C., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102925 · Cited by 446 · cited 2×
“Another pathophysiological mechanism linked to neutrophils in severe COVID-19 is the increase in platelet-neutrophil aggregates that contribute to increased levels of NET formation (67, 74, 75).”
BackgroundA Neutrophil Timer Coordinates Immune Defense and Vascular Protection
Adrover, J. M., del Fresno, C., Crainiciuc, G., Cuartero, M. I., Casanova-Acebes, M., Weiss, L. A., Huerga-Encabo, H., Silvestre-Roig, C., Rossaint, J., Cossío, I., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.01.002 · Cited by 445 · cited 4×
“This process has recently been linked to the circadian rhythm with a peak of freshly released neutrophils at night (18).”
BackgroundInfluentialNeutrophils in Homeostasis, Immunity, and Cancer
Nicolás-Ávila, J. Á., Adrover, J. M., & Hidalgo, A. (2017) · Immunity · doi:10.1016/j.immuni.2016.12.012 · Cited by 403 · cited 1×
“A switch in chemokine receptor expression from CXCR4 to CXCR2, finally, leads to the egress of mature neutrophils from the BM into the circulation (16, 17).”
BackgroundA comprehensive single cell transcriptional landscape of human hematopoietic progenitors
Pellin, D., Loperfido, M., Baricordi, C., Wolock, S. L., Montepeloso, A., Weinberg, O. K., Biffi, A., Klein, A. M., & Biasco, L. (2019) · Nature Communications · doi:10.1038/s41467-019-10291-0 · Cited by 360 · cited 1×
“However, hematopoietic structures including progenitor populations in fetal bone marrow and umbilical blood (10) are highly similar between mouse and human (24).”
BackgroundHidalgo, A., Chang, J., Jang, J.-E., Peired, A. J., Chiang, E. Y., & Frenette, P. S. (2009) · Nature Medicine · doi:10.1038/nm.1939 · Cited by 358 · cited 1×
“Additionally, a growing body of evidence shows a link between neutrophils and activated platelets that guide their migration into inflamed tissue and induce NET formation (30, 31).”
BackgroundDe Santo, C., Salio, M., Masri, S. H., Lee, L. Y.-H., Dong, T., Speak, A. O., Porubsky, S., Booth, S., Veerapen, N., Besra, G. S., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36264 · Cited by 350
Wauters, E., Van Mol, P., Garg, A. D., Jansen, S., Van Herck, Y., Vanderbeke, L., Bassez, A., Boeckx, B., Malengier-Devlies, B., Timmerman, A., et al. (2021) · Cell Research · doi:10.1038/s41422-020-00455-9 · Cited by 345
Low-density granulocytes: a distinct class of neutrophils in systemic autoimmunity
Carmona-Rivera, C., & Kaplan, M. J. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0375-7 · Cited by 342 · cited 1×
“type I interferon) and NET formation (23, 50).”
BackgroundA neutrophil activation signature predicts critical illness and mortality in COVID-19
Meizlish, M. L., Pine, A. B., Bishai, J. D., Goshua, G., Nadelmann, E. R., Simonov, M., Chang, C.-H., Zhang, H., Shallow, M., Bahel, P., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020003568 · Cited by 316 · cited 2×
“In addition, plasma levels of RETN, HGF, and LCN2, typically produced by neutrophils, were recently proposed as predictive for critical illness and mortality (57).”
BackgroundMartinelli, S., Urosevic, M., Daryadel, A., Oberholzer, P. A., Baumann, C., Fey, M. F., Dummer, R., Simon, H.-U., & Yousefi, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405883200 · Cited by 293 · cited 1×
“Other important inflammatory mediators such as the complement component C5a contribute to the recruitment of neutrophils to sites of infection (28) and to the activation of NET formation when primed by interferons (29).”
BackgroundMultiple Roles for Chemokines in Neutrophil Biology
Capucetti, A., Albano, F., & Bonecchi, R. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01259 · Cited by 285 · cited 2×
“Circulating CXCR1CXCR2 mature neutrophils are orchestrated to tissues by gradients of CXCL1, CXCL2, CXCL8, CCL3, and CCL2 (26).”
BackgroundProgrammed ‘disarming’ of the neutrophil proteome reduces the magnitude of inflammation
Adrover, J. M., Aroca-Crevillén, A., Crainiciuc, G., Ostos, F., Rojas-Vega, Y., Rubio-Ponce, A., Cilloniz, C., Bonzón-Kulichenko, E., Calvo, E., Rico, D., et al. (2020) · Nature Immunology · doi:10.1038/s41590-019-0571-2 · Cited by 282 · cited 4×
“This homeostatic program ensures protection from excessive inflammation and vascular damage by the gradual loss of granule proteins that reduces the neutrophils’ toxic activities (15).”
BackgroundInfluentialHuman neutrophils in the saga of cellular heterogeneity: insights and open questions
Scapini, P., Marini, O., Tecchio, C., & Cassatella, M. A. (2016) · Immunological Reviews · doi:10.1111/imr.12448 · Cited by 274
Kwok, I., Becht, E., Xia, Y., Ng, M., Teh, Y. C., Tan, L., Evrard, M., Li, J. L. Y., Tran, H. T. N., Tan, Y., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.06.005 · Cited by 264 · cited 1×
“However, hematopoietic structures including progenitor populations in fetal bone marrow and umbilical blood (10) are highly similar between mouse and human (24).”
BackgroundCXCR2 Antagonist MK-7123. A Phase 2 Proof-of-Concept Trial for Chronic Obstructive Pulmonary Disease
Rennard, S. I., Dale, D. C., Donohue, J. F., Kanniess, F., Magnussen, H., Sutherland, E. R., Watz, H., Lu, S., Stryszak, P., Rosenberg, E., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201405-0992oc · Cited by 261 · cited 1×
“An example is Navarixin (MK7123/SCH 527123) which showed the potential to improve lung function in COPD patients (90).”
BackgroundDisease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients
(DeCOI), G. C.-1. O. I., Aschenbrenner, A. C., Mouktaroudi, M., Krämer, B., Oestreich, M., Antonakos, N., Nuesch-Germano, M., Gkizeli, K., Bonaguro, L., Reusch, N., et al. (2021) · Genome Medicine · doi:10.1186/s13073-020-00823-5 · Cited by 255 · cited 2×
“Increased neutrophil counts have also been detected in the clinics as a feature of COVID-19 in the blood (2–4) and neutrophil activation signatures are a prominent feature of blood transcriptomes of severe cases (57, 58).”
BackgroundSelf-citationChen, L., Long, X., Xu, Q., Tan, J., Wang, G., Cao, Y., Wei, J., Luo, H., Zhu, H., Huang, L., et al. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0492-x · Cited by 251
How Glucocorticoids Affect the Neutrophil Life
Ronchetti, S., Ricci, E., Migliorati, G., Gentili, M., & Riccardi, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19124090 · Cited by 249 · cited 2×
“Corticosteroids are a currently recommended treatment for severe COVID-19 (104) shown to reduce neutrophils’ respiratory burst and recruitment to the inflamed tissue at system level (105) and inhaled glucocorticoids have been shown to reduce NET formation in asthma patients (106).”
BackgroundMyeloid-Derived Suppressor Cell Subsets Drive Glioblastoma Growth in a Sex-Specific Manner
Bayik, D., Zhou, Y., Park, C., Hong, C., Vail, D., Silver, D. J., Lauko, A., Roversi, G., Watson, D. C., Lo, A., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-1355 · Cited by 245
Uhel, F., Azzaoui, I., Grégoire, M., Pangault, C., Dulong, J., Tadié, J.-M., Gacouin, A., Camus, C., Cynober, L., Fest, T., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201606-1143oc · Cited by 243 · cited 1×
“The pro-Neu are characterized by genes involved in NET formation including MPO, ELANE, PRTN3 whereas the pre-Neu present with CD177, CD24, OLFM4, LCN2 and BPI expression, genes which have been associated with poor outcome in sepsis (60, 61).”
BackgroundArcanjo, A., Logullo, J., Menezes, C. C. B., de Souza Carvalho Giangiarulo, T. C., dos Reis, M. C., de Castro, G. M. M., da Silva Fontes, Y., Todeschini, A. R., Freire-de-Lima, L., Decoté-Ricardo, D., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-76781-0 · Cited by 241 · cited 2×
“Indeed, serum from severe COVID19 patients induces NET formation (67, 71), which might at least in part be explained by autoantibodies as the incubation of the IgG antibody fraction from severe COVID-19 patients was sufficient to induce NET formation in neutrophils from healthy”
BackgroundBlood coagulation in immunothrombosis—At the frontline of intravascular immunity
Gaertner, F., & Massberg, S. (2016) · Seminars in Immunology · doi:10.1016/j.smim.2016.10.010 · Cited by 232 · cited 1×
“Together, neutrophils and activated platelets can elicit a process termed immunothrombosis in blood vessels where they contribute to the formation of a fibrin mesh that can trap pathogens (32), but more importantly intravascular NET formation by itself can lead to the fibrin-independent occlusion of microvessels causi…”
BackgroundExpansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19)
Agrati, C., Sacchi, A., Bordoni, V., Cimini, E., Notari, S., Grassi, G., Casetti, R., Tartaglia, E., Lalle, E., D’Abramo, A., et al. (2020) · Cell Death & Differentiation · doi:10.1038/s41418-020-0572-6 · Cited by 229 · cited 1×
“Later studies were able to isolate MDSClike neutrophils fromCOVID-19 patients and provided evidence for their capacity to inhibit T cell proliferation and IFNg production (64, 65).”
ResultHypoxia, HIF-1α, and COVID-19: from pathogenic factors to potential therapeutic targets
Serebrovska, Z. O., Chong, E. Y., Serebrovska, T. V., Tumanovska, L. V., & Xi, L. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-00554-8 · Cited by 218
Impaired efferocytosis and neutrophil extracellular trap clearance by macrophages in ARDS
Grégoire, M., Uhel, F., Lesouhaitier, M., Gacouin, A., Guirriec, M., Mourcin, F., Dumontet, E., Chalin, A., Samson, M., Berthelot, L.-L., et al. (2018) · European Respiratory Journal · doi:10.1183/13993003.02590-2017 · Cited by 216 · cited 1×
“In addition, NET formation may not only activate alveolar macrophages for clearance (40), but also largely contributes to the activation of endothelial cells exacerbating the inflammatory circuit (37) or can actively damage endothelial tissue (41).”
BackgroundThe lung is a host defense niche for immediate neutrophil-mediated vascular protection
Yipp, B. G., Kim, J. H., Lima, R., Zbytnuik, L. D., Petri, B., Swanlund, N., Ho, M., Szeto, V. G., Tak, T., Koenderman, L., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aam8929 · Cited by 213 · cited 1×
“Further, the lung microvasculature has been recognized as a functional immune niche (21, 22).”
BackgroundIFN-γ-Stimulated Neutrophils Suppress Lymphocyte Proliferation through Expression of PD-L1
de Kleijn, S., Langereis, J. D., Leentjens, J., Kox, M., Netea, M. G., Koenderman, L., Ferwerda, G., Pickkers, P., & Hermans, P. W. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072249 · Cited by 203 · cited 1×
“Moreover, two mature neutrophil clusters were found to be specific for severe disease course and resemble phenotypes of granulocytic MDSCs (62) and PD-L1 neutrophils after LPS challenge in vivo (63).”
BackgroundPhase II study of a neutrophil elastase inhibitor (AZD9668) in patients with bronchiectasis
Stockley, R., De Soyza, A., Gunawardena, K., Perrett, J., Forsman-Semb, K., Entwistle, N., & Snell, N. (2013) · Respiratory Medicine · doi:10.1016/j.rmed.2012.12.009 · Cited by 201
Vlaar, A. P. J., de Bruin, S., Busch, M., Timmermans, S. A. M. E. G., van Zeggeren, I. E., Koning, R., ter Horst, L., Bulle, E. B., van Baarle, F. E. H. P., van de Poll, M. C. G., et al. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30341-6 · Cited by 194
Annane, D., Heming, N., Grimaldi-Bensouda, L., Frémeaux-Bacchi, V., Vigan, M., Roux, A.-L., Marchal, A., Michelon, H., Rottman, M., & Moine, P. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100590 · Cited by 177
The role of C5a in acute lung injury induced by highly pathogenic viral infections
Wang, R., Xiao, H., Guo, R., Li, Y., & Shen, B. (2015) · Emerging Microbes & Infections · doi:10.1038/emi.2015.28 · Cited by 170 · cited 2×
“The C5a molecule was found to increase proportionally with COVID-19 severity (101) and is known to induce neutrophil recruitment as well as activation by binding the C5aR1 receptor (28).”
BackgroundWith Friends Like These: The Complex Role of Neutrophils in the Progression of Severe Pneumonia
Pechous, R. D. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00160 · Cited by 170 · cited 2×
“In addition, NET formation may not only activate alveolar macrophages for clearance (40), but also largely contributes to the activation of endothelial cells exacerbating the inflammatory circuit (37) or can actively damage endothelial tissue (41).”
BackgroundHypoxia: A key feature of COVID-19 launching activation of HIF-1 and cytokine storm
Jahani, M., Dokaneheifard, S., & Mansouri, K. (2020) · Journal of Inflammation · doi:10.1186/s12950-020-00263-3 · Cited by 169
COVID-19–Associated Nonocclusive Fibrin Microthrombi in the Heart
Bois, M. C., Boire, N. A., Layman, A. J., Aubry, M.-C., Alexander, M. P., Roden, A. C., Hagen, C. E., Quinton, R. A., Larsen, C., Erben, Y., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.050754 · Cited by 164
Vollbrecht, T., Stirner, R., Tufman, A., Roider, J., Huber, R. M., Bogner, J. R., Lechner, A., Bourquin, C., & Draenert, R. (2012) · AIDS · doi:10.1097/qad.0b013e328354b43f · Cited by 151
Mare, T. A., Treacher, D. F., Shankar-Hari, M., Beale, R., Lewis, S. M., Chambers, D. J., & Brown, K. A. (2015) · Critical Care · doi:10.1186/s13054-015-0778-z · Cited by 149
On the origin of low-density neutrophils
Hassani, M., Hellebrekers, P., Chen, N., van Aalst, C. W., Bongers, S., Hietbrink, F., Koenderman, L., & Vrisekoop, N. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.5hr0120-459r · Cited by 149 · cited 1×
“This type of neutrophil co‐segregates with mononuclear cells after density gradient centrifugation of blood, thus termed lowdensity neutrophils (LDNs) (49).”
BackgroundParačková, Z., Zentsová, I., Bloomfield, M., Vrabcová, P., Smetanová, J., Klocperk, A., Mesežnikov, G., Méndez, L. F. C., Vymazal, T., & Šedivá, A. (2020) · Cells · doi:10.3390/cells9102206 · Cited by 147
Cloke, T., Munder, M., Taylor, G. P., Müller, I., & Kropf, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048939 · Cited by 142 · cited 4×
“Moreover, two mature neutrophil clusters were found to be specific for severe disease course and resemble phenotypes of granulocytic MDSCs (62) and PD-L1+ neutrophils after LPS challenge in vivo (63).”
BackgroundInfluentialTargeting Neutrophils to Treat Acute Respiratory Distress Syndrome in Coronavirus Disease
Chiang, C.-C., Kořínek, M., Cheng, W.-J., & Hwang, T. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.572009 · Cited by 131 · cited 2×
“Due to the current need of additional therapeutic options for severe COVID-19 patients, several strategies are under clinical investigation targeting different aspects of the host response to SARS-CoV-2 infection (89).”
BackgroundSingle-Cell Profiling of Ebola Virus Disease In Vivo Reveals Viral and Host Dynamics
Kotliar, D., Lin, A. E., Logue, J., Hughes, T. K., Khoury, N. M., Raju, S. S., Wadsworth, M. H., Chen, H. M., Kurtz, J. R., Dighero-Kemp, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.002 · Cited by 128
Sacchi, A., Grassi, G., Bordoni, V., Lorenzini, P., Cimini, E., Casetti, R., Tartaglia, E., Marchioni, L., Petrosillo, N., Palmieri, F., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03125-1 · Cited by 126 · cited 1×
“Later studies were able to isolate MDSClike neutrophils fromCOVID-19 patients and provided evidence for their capacity to inhibit T cell proliferation and IFNg production (64, 65).”
ResultNarasaraju, T., Tang, B. M. P., i, M. H., Muller, S., Chow, V. T. K., & Radic, M. Z. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00870 · Cited by 126 · cited 1×
“Further, the aforementioned Navarixin, together with other CXCR2 inhibitors, has been proposed as treatment for COVID-19 (95).”
BackgroundBlocking IL-1 to prevent respiratory failure in COVID-19
van de Veerdonk, F. L., & Netea, M. G. (2020) · Critical Care · doi:10.1186/s13054-020-03166-0 · Cited by 122
Anakinra treatment in critically ill COVID-19 patients: a prospective cohort study
the RCI-COVID-19 Study Group, Kooistra, E. J., Waalders, N. J. B., Grondman, I., Janssen, N. A. F., de Nooijer, A. H., Netea, M. G., van de Veerdonk, F. L., Ewalds, E., van der Hoeven, J. G., et al. (2020) · Critical Care · doi:10.1186/s13054-020-03364-w · Cited by 119
Dinh, H. Q., Eggert, T., Meyer, M. A., Zhu, Y. P., Olingy, C. E., Llewellyn, R., Wu, R., & Hedrick, C. C. (2020) · Immunity · doi:10.1016/j.immuni.2020.07.017 · Cited by 118
Neutrophil Extracellular Traps Effectively Control Acute Chikungunya Virus Infection
Hiroki, C. H., Toller-Kawahisa, J. E., Fumagalli, M. J., Colón, D. F., Figueiredo, L. T. M., Fonseca, B. A. L. D., França, R. F. D. O., & Cunha, F. Q. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03108 · Cited by 118 · cited 1×
“NET formation in the lungs may additionally be triggered by direct contact of neutrophils with SARS-CoV-2 as in vitro stimulations with the virus induced NET formation likely via TLR7 signalling (70, 71, 73).”
BackgroundThe Impact of Hypoxia on Neutrophil Degranulation and Consequences for the Host
Lodge, K. M., Cowburn, A. S., Li, W., & Condliffe, A. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041183 · Cited by 114 · cited 1×
“The HIF pathway has been described to increase the expression of antimicrobial peptides and promote degranulation, but on the other hand might inhibit ROS production and NET formation (35).”
BackgroundYergin, C. G., Roggerson, K. M., Lee, H., Golden‐Mason, L., Rosen, H. R., & Hahn, Y. S. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501881 · Cited by 112 · cited 1×
“So-called granulocytic myeloid-derived suppressor cells (MDSC), originally identified in cancer (42, 43), have now additionally been described in multiple viral chronic infections, such as HCV (44) and HIV (45–47), to inhibit lymphocyte proliferation via depletion of arginine by Arginase-1 (48) or through the expressi…”
BackgroundNicolai, L., Leunig, A., Brambs, S., Kaiser, R. W. J., Joppich, M., Hoffknecht, M., Gold, C., Engel, A., Polewka, V., Muenchhoff, M., et al. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.15179 · Cited by 108
Olfactomedin-4 Is a Candidate Marker for a Pathogenic Neutrophil Subset in Septic Shock
Alder, M. N., Opoka, A. M., Lahni, P., Hildeman, D. A., & Wong, H. R. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002102 · Cited by 100 · cited 1×
“The pro-Neu are characterized by genes involved in NET formation including MPO, ELANE, PRTN3 whereas the pre-Neu present with CD177, CD24, OLFM4, LCN2 and BPI expression, genes which have been associated with poor outcome in sepsis (60, 61).”
BackgroundKarmouty‐Quintana, H., Thandavarayan, R. A., Keller, S. P., Sahay, S., Pandit, L. M., & Akkanti, B. H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218081 · Cited by 61 · cited 1×
“The risk of immunothrombosis is further increased by vasoconstriction caused by the cytokine release syndrome observed in severe COVID-19 (76) or by hypoxic pulmonary vasoconstriction which is possibly dysregulated in severe COVID-19 (77, 78).”
BackgroundThe Lung Microvasculature Is a Functional Immune Niche
Granton, E., Kim, J. H., Podstawka, J., & Yipp, B. G. (2018) · Trends in Immunology · doi:10.1016/j.it.2018.09.002 · Cited by 53 · cited 1×
“Further, the lung microvasculature has been recognized as a functional immune niche (21, 22).”
BackgroundThe Complement C5a-C5aR1 GPCR Axis in COVID-19 Therapeutics
Woodruff, T. M., & Shukla, A. K. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.09.008 · Cited by 46 · cited 1×
“The complement C5a-C5aR1 interaction also appears to be a candidate in the modulation of neutrophil-induced tissue damage (100).”
BackgroundGál, Z., Gézsi, A., Pállinger, É., Visnovitz, T., Nagy, A., Kiss, A., Sultész, M., Csoma, Z., Tamási, L., Gálffy, G., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-61253-2 · Cited by 37 · cited 1×
“Corticosteroids are a currently recommended treatment for severe COVID-19 (104) shown to reduce neutrophils’ respiratory burst and recruitment to the inflamed tissue at system level (105) and inhaled glucocorticoids have been shown to reduce NET formation in asthma patients (106).”
BackgroundDomínguez‐Luis, M. J., Armas‐González, E., Herrera-García, A., Arce-Franco, M. T., Feria, M., Vicente‐Manzanares, M., Martínez-Ruiz, A., Sánchez‐Madrid, F., & Díaz‐González, F. (2018) · European Journal of Immunology · doi:10.1002/eji.201847710 · Cited by 32 · cited 1×
“Binding of these chemokines does not only guide the localization, but also activates them as demonstrated by CXCL8 that can elicit ROS production and induce L-Selectin shedding (27).”
BackgroundPan, R., Chen, Y., Vaine, M., Hu, G., Wang, S., Lu, S., & Kong, X. (2015) · Emerging Microbes & Infections · doi:10.1038/emi.2015.44 · Cited by 30
Dross, S., Munson, P. V., Kim, S. E., Bratt, D., Tunggal, H. C., Gervassi, A. L., FULLER, D. H., & Horton, H. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1600759 · Cited by 29
Drabczyk-Pluta, M., Werner, T., Hoffmann, D. E., Leng, Q., Chen, L., Dittmer, U., & Zelinskyy, G. (2017) · Retrovirology · doi:10.1186/s12977-017-0364-3 · Cited by 25 · cited 1×
“So-called granulocytic myeloid-derived suppressor cells (MDSC), originally identified in cancer (42, 43), have now additionally been described in multiple viral chronic infections, such as HCV (44) and HIV (45–47), to inhibit lymphocyte proliferation via depletion of arginine by Arginase-1 (48) or through the expressi…”
Background
Cited by
The role of neutrophil extracellular traps in acute lung injury
Scozzi, D., Liao, F., Krupnick, A. S., Kreisel, D., & Gelman, A. E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.953195 · Cited by 218
COVID-19 and cellular senescence
Schmitt, C. A., Tchkonia, T., Niedernhofer, L. J., Robbins, P. D., Kirkland, J. L., & Lee, S. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00785-2 · Cited by 153
Metadata
- Authors
- Reusch, N., De Domenico, E., Bonaguro, L., Schulte-Schrepping, J., Baßler, K., Schultze, J. L., & Aschenbrenner, A. C.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2021-03-25
- Volume
- 12
- Pages
- 652470-652470
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W3138641401
- Cited by
- 249
- References
- 104
- FWCI
- 17.03
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.